1. Home
  2. PRAX vs WAL Comparison

PRAX vs WAL Comparison

Compare PRAX & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$312.37

Market Cap

8.8B

Sector

Health Care

ML Signal

HOLD

Logo Western Alliance Bancorporation (DE)

WAL

Western Alliance Bancorporation (DE)

HOLD

Current Price

$91.17

Market Cap

9.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
WAL
Founded
2015
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
9.7B
IPO Year
2020
2005

Fundamental Metrics

Financial Performance
Metric
PRAX
WAL
Price
$312.37
$91.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
14
Target Price
$397.85
$98.93
AVG Volume (30 Days)
623.7K
774.0K
Earning Date
02-27-2026
01-26-2026
Dividend Yield
N/A
1.77%
EPS Growth
N/A
24.99
EPS
N/A
8.09
Revenue
$7,463,000.00
$3,189,400,000.00
Revenue This Year
N/A
$16.21
Revenue Next Year
$14,827.76
$9.13
P/E Ratio
N/A
$10.60
Revenue Growth
364.98
9.57
52 Week Low
$26.70
$57.05
52 Week High
$326.91
$94.40

Technical Indicators

Market Signals
Indicator
PRAX
WAL
Relative Strength Index (RSI) 63.20 60.44
Support Level $266.93 $85.62
Resistance Level $326.91 $90.77
Average True Range (ATR) 17.87 2.42
MACD 0.13 -0.05
Stochastic Oscillator 75.94 92.64

Price Performance

Historical Comparison
PRAX
WAL

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

About WAL Western Alliance Bancorporation (DE)

Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.

Share on Social Networks: